People: Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

0.52USD
23 Oct 2014
Price Change (% chg)

$-0.02 (-4.01%)
Prev Close
$0.54
Open
$0.55
Day's High
$0.56
Day's Low
$0.52
Volume
66,640
Avg. Vol
342,284
52-wk High
$2.25
52-wk Low
$0.44

Search Stocks

Summary

Name Age Since Current Position

Jerald Wenker

2014 Chairman of the Board

Andre Godin

2014 Interim President and Chief Executive Officer

Pierre Lemieux

2010 Chief Operating Officer

Harlan Waksal

60 2011 Executive Vice President - Business and Scientific Affairs

Tina Sampalis

2012 Chief Global Strategy Officer

Henri Harland

2014 Secretary, Director

Ronald Denis

2014 Director

Reed Tuckson

2013 Independent Director

Biographies

Name Description

Jerald Wenker

Andre Godin

Mr. Andre Godin an Interim President and Chief Executive Officer of the Company. Andre has been with Neptune since 2003 and has played an active leadership role in all aspects of the organization. He is a chartered professional accountant and also has more than 20 years of industry experience, including as former president of a dietary supplement company and as a corporate controller for a pharmaceutical company in over-the-counter (OTC) products.

Pierre Lemieux

Dr. Pierre Lemieux Ph.D. is a Chief Operating Officer of Acasti Pharma Inc.,

Harlan Waksal

Dr. Harlan W. Waksal, M.D., serves as Executive Vice President - Business and Scientific Affairs of Acasti Pharma Inc., since July 2011. Dr. Waksal is a physician and co-founder of ImClone System Inc., where he was instrumental in the development of, and obtaining FDA approval for, a biologic cancer therapy.

Tina Sampalis

Dr. Tina Sampalis M.D., Ph.D. is a Chief Global Strategy Officer of Acasti Pharma Inc.,

Henri Harland

Mr. Henri Harland serves as Secretary, Director of Acasti Pharma Ltd. He resigned as President, Chief Executive Officer of the Company effective April 28, 2014. Mr. Harland is an Actuary and holds a MBA (Finance) from Laval University. Mr. Henri Harland has been a director as well as the President and Chief Executive Officer of Neptune since its incorporation on October 9, 1998. He is the founder of the Corporation and of Neptune and has been involved in the krill research project since 1991. For more than ten years he has held the position of President and Chief Executive Officer of Gestion Harland Inc., a financial engineering group. Previously, he acted as an independent financial consultant for companies in different industrial sectors in both North America and Europe guiding them through recapitalization, financing and business development.

Ronald Denis

Dr. Ronald Denis is Director of Acasti Pharma Inc. Dr. Ronald Denis has been Chief of Surgery and director of the Trauma Program at Hôpital du Sacré-Coeur in Montréal since 1997. Since 1987, Dr. Denis has also been medical co-director of the Canadian Formula 1 Grand Prix. Dr. Denis sits on several scientific boards and management committees.

Reed Tuckson

Dr. Reed V. Tuckson, M.D., has been appointed as Independent Director of Acasti Pharma Inc., with effect from 5 November 2013. Dr. Tuckson is currently the managing director of Tuckson Health Connections LLC, a health and medical care consulting business. Previously, he served a long tenure as executive vice-president and chief of medical affairs for UnitedHealth Group, a Fortune 25 health and well-being company, which includes the United States' largest health insurer and the industry's most comprehensive health services company. Among his many committee memberships, Dr. Tuckson is member of the advisory committee to the director of the National Institutes of Health and is also an active member of the Institute of Medicine of the National Academy of Sciences. He also serves on the boards of the American Telemedicine Association, Howard University and Cell Therapeutics Inc., a public corporation. Dr. Tuckson has been noted several times by Modern Healthcare Magazine as one of the 50 most powerful physician executives in health care and Black Enterprise Magazine featured him as one of the most powerful executives in corporate America. Dr. Tuckson is a graduate of Howard University, Georgetown University's school of medicine, and the hospital of the University of Pennsylvania's general internal medicine residency and fellowship programs, where he was also a Robert Wood Johnson Foundation clinical scholar studying at the Wharton School of Business.

Basic Compensation

Name Fiscal Year Total

Jerald Wenker

--

Andre Godin

89,100

Pierre Lemieux

358,725

Harlan Waksal

306,533

Tina Sampalis

362,161

Henri Harland

475,061

Ronald Denis

--

Reed Tuckson

--
As Of 27 Feb 2013

Options Compensation

Search Stocks